The New Flash At KodakMark Maremont
Say one thing for George M.C. Fisher: He doesn't shy away from big decisions. A scant five months after taking over as Eastman Kodak Co.'s CEO, Fisher stunned outsiders on May 3 by announcing that Kodak would auction off three big units, including the Sterling Drug Inc. operations bought in 1988 for $5.1 billion. In a single stroke, Fisher repudiated the failed diversification strategy of his predecessors, shored up a debt-laden balance sheet, and underscored his commitment to Kodak's imaging business.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.